| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $18,183,588 | 11 | 100 |
Sells | $0 | 0 | 0 |
| Manning Paul B | 1 | $17.51M | 0 | $0 | $17.51M | |
| Rieger Jayson | CEO and President | 3 | $525,864 | 0 | $0 | $525,864 |
| Zawitz David | Chief Operating Officer | 2 | $72,305 | 0 | $0 | $72,305 |
| Rosenberg Noah L. | CMO | 3 | $40,609 | 0 | $0 | $40,609 |
| Kirby John J. | Interim CFO | 2 | $39,651 | 0 | $0 | $39,651 |
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of …
Over the last 12 months, insiders at Verrica Pharmaceuticals Inc. have bought $18.18M and sold $0 worth of Verrica Pharmaceuticals Inc. stock.
On average, over the past 5 years, insiders at Verrica Pharmaceuticals Inc. have bought $13.48M and sold $738,407 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Manning Paul B () — $17.51M. Rieger Jayson (CEO and President) — $525,864. Zawitz David (Chief Operating Officer) — $72,305.
The last purchase of 5,000 shares for transaction amount of $24,650 was made by Kirby John J. (Interim CFO) on 2026‑08‑18.
| 2026-08-18 | Kirby John J. | Interim CFO | 5,000 0.0307% | $4.93 | $24,650 | -4.38% | ||
| 2026-08-18 | Rosenberg Noah L. | CMO | 2,030 0.0124% | $4.92 | $9,988 | -4.38% | ||
| 2026-08-17 | Rieger Jayson | CEO and President | 5,000 0.0236% | $4.91 | $24,550 | -8.18% | ||
| 2026-08-17 | Zawitz David | Chief Operating Officer | 6,000 0.0287% | $4.98 | $29,880 | -8.18% | ||
| 2026-08-17 | Rosenberg Noah L. | CMO | 4,200 0.0198% | $4.91 | $20,622 | -8.18% | ||
| 2026-08-14 | Rieger Jayson | CEO and President | 20,000 0.0956% | $5.06 | $101,200 | -9.46% | ||
| 2025-11-25 | Manning Paul B | 4.13M 43.8143% | $4.24 | $17.51M | +13.28% | |||
| 2025-11-25 | Rieger Jayson | CEO and President | 94,311 1.0015% | $4.24 | $400,114 | +13.28% | ||
| 2025-11-25 | Zawitz David | Chief Operating Officer | 10,000 0.1062% | $4.24 | $42,425 | +13.28% | ||
| 2025-11-25 | Kirby John J. | Interim CFO | 3,536 0.0375% | $4.24 | $15,001 | +13.28% | ||
| 2025-11-25 | Rosenberg Noah L. | CMO | 2,357 0.025% | $4.24 | $10,000 | +13.28% | ||
| 2025-03-17 | Sale | Hayes Christopher G. | CHIEF LEGAL OFFICER | 4,315 0.0047% | $0.65 | $2,805 | -12.75% | |
| 2024-11-22 | Manning Paul B | 22.92M 45.1241% | $0.89 | $20.4M | -40.00% | |||
| 2024-11-22 | Stalfort John A III | director | 1.12M 2.212% | $0.89 | $1,000,000 | -40.00% | ||
| 2024-11-22 | Rieger Jayson | CEO and President | 280,898 0.553% | $0.89 | $249,999 | -40.00% | ||
| 2024-08-27 | Sale | White Ted | PRESIDENT AND CEO | 9,021 0.0211% | $2.46 | $22,192 | -72.56% | |
| 2024-08-27 | Sale | Hayes Christopher G. | CHIEF LEGAL OFFICER | 9,530 0.0223% | $2.46 | $23,444 | -72.56% | |
| 2024-08-27 | Sale | Goldenberg Gary | Chief Medical Officer | 3,601 0.0084% | $2.46 | $8,858 | -72.56% | |
| 2024-08-27 | Sale | Bonaccorso Joe | CHIEF COMMERCIAL OFFICER | 8,993 0.0211% | $2.46 | $22,123 | -72.56% | |
| 2024-08-27 | Sale | Kohler Terry | CHIEF FINANCIAL OFFICER | 7,899 0.0185% | $2.46 | $19,432 | -72.56% |
| Manning Paul B | 3958189 23.0411% | $13.02M | 20 | 0 | +4.54% | |
| Rieger Jayson | CEO and President | 207593 1.2084% | $682,980.97 | 4 | 0 | <0.0001% |
| Zawitz David | Chief Operating Officer | 27000 0.1572% | $88,830.00 | 2 | 0 | |
| Kirby John J. | Interim CFO | 23962 0.1395% | $78,834.98 | 2 | 0 | |
| Rosenberg Noah L. | CMO | 8587 0.05% | $28,251.23 | 3 | 0 | |
| PERCEPTIVE ADVISORS LLC | 10 percent owner | 7099182 41.3253% | $23.36M | 10 | 0 | <0.0001% |
| EDELMAN JOSEPH | 5038983 29.3326% | $16.58M | 1 | 0 | +61.6% | |
| Stalfort John A III | director | 1823800 10.6166% | $6M | 5 | 0 | +33.13% |
| White Ted | PRESIDENT AND CEO | 215967 1.2572% | $710,531.43 | 7 | 7 | +0.47% |
| Hayes Christopher G. | CHIEF LEGAL OFFICER | 176458 1.0272% | $580,546.82 | 3 | 8 | +53.25% |
| Goldenberg Gary | Chief Medical Officer | 94261 0.5487% | $310,118.69 | 1 | 7 | +61.6% |
| Bonaccorso Joe | CHIEF COMMERCIAL OFFICER | 73114 0.4256% | $240,545.06 | 1 | 7 | <0.0001% |
| DAVIS A BRIAN | Chief Financial Officer | 12900 0.0751% | $42,441.00 | 2 | 0 | +77.03% |
| Ballaron Craig | director | 10000 0.0582% | $32,900.00 | 2 | 0 | +25.32% |
| Palczuk Linda | Chief Operating Officer | 8500 0.0495% | $27,965.00 | 3 | 0 | <0.0001% |
| Degnan Chris | Chief Financial Officer | 3000 0.0175% | $9,870.00 | 1 | 0 | <0.0001% |
$5,831,763 | 118 | -33.78% | $66.68M | |
$17,525,882 | 60 | 5.22% | $64.7M | |
Verrica Pharmaceuticals Inc. (VRCA) | $103,288,323 | 51 | 4.78% | $56.52M |
$19,705,388 | 47 | 86.26% | $67.15M | |
$24,478,755 | 37 | -34.59% | $53.59M |
| Increased Positions | 27 | +52.94% | 3M | +119.45% |
| Decreased Positions | 19 | -37.25% | 233,457 | -9.44% |
| New Positions | 22 | New | 2M | New |
| Sold Out Positions | 9 | Sold Out | 10,745 | Sold Out |
| Total Postitions | 59 | +15.69% | 5M | +110.01% |
| Caligan Partners Lp | $7,668.00 | 5.77% | 923,910 | -2 | 0% | 2025-09-30 |
| Armistice Capital, Llc | $5,305.00 | 4% | 639,193 | -248,941 | -28.03% | 2025-09-30 |
| Boothbay Fund Management, Llc | $2,330.00 | 1.76% | 280,734 | +280,734 | New | 2025-09-30 |
| Vanguard Group Inc | $1,869.00 | 1.41% | 225,210 | +8,379 | +3.86% | 2025-09-30 |
| Sovran Advisors, Llc | $613.00 | 0.46% | 73,805 | -1,234 | -1.64% | 2025-09-30 |
| Millennium Management Llc | $598.00 | 0.45% | 71,990 | -18,718 | -20.64% | 2025-09-30 |
| Geode Capital Management, Llc | $562.00 | 0.42% | 67,659 | +3,043 | +4.71% | 2025-09-30 |
| Ubs Group Ag | $346.00 | 0.26% | 41,632 | +34,359 | +472.42% | 2025-09-30 |
| Renaissance Technologies Llc | $242.00 | 0.18% | 29,191 | +20,471 | +234.76% | 2025-09-30 |
| Mariner, Llc | $204.00 | 0.15% | 24,550 | -1,980 | -7.46% | 2025-09-30 |